-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, with the advancement of a series of medical reform policies such as the three-medicine linkage and hierarchical diagnosis and treatment, the outflow of prescriptions has become a general trend
.
Since 2021, this trend is still intensifying
.
New policies have been promulgated continuously and are continuing to inject "cardiotonic agents" into the pharmaceutical retail market
.
For example, on February 1 this year, the "Interim Measures for the Management of Medical Security for Retail Pharmacies" issued by the National Medical Insurance Administration was formally implemented.
The supervision of designated pharmacies has been regulated and clarified
.
Among them, it encourages the docking of pooled accounts to retail pharmacies to further promote the outflow of prescription drugs; on April 15, China’s "Opinions on Services for the "Six Stability" and "Six Guarantees" to Further Do a Good Job in the Reform of "Decentralization, Management and Service"" also made clear It was pointed out that under the premise of ensuring the authenticity and reliability of the source of electronic prescriptions, online sales of prescription drugs other than those under special management by the state are allowed
.
In the industry's view, this also means that online prescription drugs will be fully liberalized
.
The industry believes that in the context of the intensified prescription outflow trend, retail pharmacies, patients and many other parties will benefit
.
A research organization reported that by 2028, the market size of prescription outflows will exceed 720 billion yuan, of which chain pharmacies will undertake 500 billion yuan
.
Some practitioners in the retail sector of pharmaceutical companies have said that with the aging of the population and the improvement of people’s awareness of life and health care, under the dual influence of policies and the market, the new ecosystem of the pharmaceutical retail industry has accelerated its layout, and the development of industry specialization and market standardization has entered Fast lane
.
Under the influence of the mass procurement policy, the prescription outflow process of China's pharmaceutical industry has been accelerating.
In the future, the drug sales channel will extend from hospitals to professional pharmacies, and the development of the pharmaceutical retail industry is very promising
.
In recent years, it can be seen that all major chain pharmacies are speeding up the race, expanding the number of stores, and enhancing their dominant position in the market competition.
.
For example, in the first three quarters of 2021, the four major chain giants will all acquire more than 1,000 stores, especially Yifeng Pharmacy’s net increase of 1,255 stores in the first nine months, of which 1051 newly opened stores (including 242 newly opened franchise stores), mergers and acquisitions There were 280 stores and 76 stores were closed.
As of the end of the reporting period, the total number of company stores was 7,246 (including 877 franchise stores), and the operating area of directly-operated stores was 742,800 square meters
.
From July to September 2021, the company added 358 stores, including 318 new stores (including 78 newly opened franchise stores), 66 mergers and acquisitions, and 26 closed stores
.
It is worth mentioning that in the context of intensified industry competition, retail companies are facing opportunities while also facing challenges, including issues such as the quality of pharmacy services and medication safety
.
On May 10, the National Medical Insurance Administration issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for National Medical Insurance Negotiation Drugs", which stipulates that, relying on a unified national medical insurance information platform, a prescription circulation center will be deployed and medical insurance agencies should be connected.
, Designated medical institutions and designated retail pharmacies to ensure the smooth circulation of electronic prescriptions
.
With the circulation of prescriptions as the core, implement the requirements of "designated institutions, designated physicians, and traceability" to realize the whole-process supervision of patients' medication behavior
.
The industry believes that under the "dual channel" policy, the threshold for future retail companies to undertake outflow prescriptions will be greatly increased, and professional capabilities are required to improve the quality of pharmaceutical services to ensure drug safety
.
.
Since 2021, this trend is still intensifying
.
New policies have been promulgated continuously and are continuing to inject "cardiotonic agents" into the pharmaceutical retail market
.
For example, on February 1 this year, the "Interim Measures for the Management of Medical Security for Retail Pharmacies" issued by the National Medical Insurance Administration was formally implemented.
The supervision of designated pharmacies has been regulated and clarified
.
Among them, it encourages the docking of pooled accounts to retail pharmacies to further promote the outflow of prescription drugs; on April 15, China’s "Opinions on Services for the "Six Stability" and "Six Guarantees" to Further Do a Good Job in the Reform of "Decentralization, Management and Service"" also made clear It was pointed out that under the premise of ensuring the authenticity and reliability of the source of electronic prescriptions, online sales of prescription drugs other than those under special management by the state are allowed
.
In the industry's view, this also means that online prescription drugs will be fully liberalized
.
The industry believes that in the context of the intensified prescription outflow trend, retail pharmacies, patients and many other parties will benefit
.
A research organization reported that by 2028, the market size of prescription outflows will exceed 720 billion yuan, of which chain pharmacies will undertake 500 billion yuan
.
Some practitioners in the retail sector of pharmaceutical companies have said that with the aging of the population and the improvement of people’s awareness of life and health care, under the dual influence of policies and the market, the new ecosystem of the pharmaceutical retail industry has accelerated its layout, and the development of industry specialization and market standardization has entered Fast lane
.
Under the influence of the mass procurement policy, the prescription outflow process of China's pharmaceutical industry has been accelerating.
In the future, the drug sales channel will extend from hospitals to professional pharmacies, and the development of the pharmaceutical retail industry is very promising
.
In recent years, it can be seen that all major chain pharmacies are speeding up the race, expanding the number of stores, and enhancing their dominant position in the market competition.
.
For example, in the first three quarters of 2021, the four major chain giants will all acquire more than 1,000 stores, especially Yifeng Pharmacy’s net increase of 1,255 stores in the first nine months, of which 1051 newly opened stores (including 242 newly opened franchise stores), mergers and acquisitions There were 280 stores and 76 stores were closed.
As of the end of the reporting period, the total number of company stores was 7,246 (including 877 franchise stores), and the operating area of directly-operated stores was 742,800 square meters
.
From July to September 2021, the company added 358 stores, including 318 new stores (including 78 newly opened franchise stores), 66 mergers and acquisitions, and 26 closed stores
.
It is worth mentioning that in the context of intensified industry competition, retail companies are facing opportunities while also facing challenges, including issues such as the quality of pharmacy services and medication safety
.
On May 10, the National Medical Insurance Administration issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for National Medical Insurance Negotiation Drugs", which stipulates that, relying on a unified national medical insurance information platform, a prescription circulation center will be deployed and medical insurance agencies should be connected.
, Designated medical institutions and designated retail pharmacies to ensure the smooth circulation of electronic prescriptions
.
With the circulation of prescriptions as the core, implement the requirements of "designated institutions, designated physicians, and traceability" to realize the whole-process supervision of patients' medication behavior
.
The industry believes that under the "dual channel" policy, the threshold for future retail companies to undertake outflow prescriptions will be greatly increased, and professional capabilities are required to improve the quality of pharmaceutical services to ensure drug safety
.
